CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
REFILE-Long-term HIV viral suppression tied to lower cancer risk
Insurers increasingly deny coverage for all-oral hepatitis C regimens
Sofosbuvir-velpatasvir-voxilaprevir effective in previously treated chronic hep C
Israeli company Galmed gets positive trial results for liver drug
Long-term HIV viral suppression tied to lower cancer risk
View Complete News Library
August 10-11
Advanced Hepatology Educational Summit for 3rd Year Fellows
Chicago, IL, USA
August 19-22
NCAD - National Conference on Addiction Disorders
Anaheim, CA, USA
September 7-9
GHAPP - Gastroenterology & Hepatology Advanced Practice Providers
Las Vegas, NV, USA
September 20-23
ALEH - Asociación Latinoamericana para el Estudio del Hígado (ALEH) / Latin American Association for the Study of the Liver
Punta Cana, Dominican Republic
October 3-7
IDSA - Infectious Diseases Society of America
San Francisco, CA, USA
View all Congresses
  Featured Abstracts          
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients with Nonalcoholic Steatohepatitis
Community-Based Services to Improve Testing and Linkage to Care Among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection - Three U.S. Programs, October 2014-September 2017
Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening
Improvement of Hepatic Fibrosis and Patient-Reported Outcomes in Non-Alcoholic Steatohepatitis Treated with Selonsertib
Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans
Treatment of hepatitis B: Is there still a role for interferon?
Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis Ccirrhosis and metabolic risk factors
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B
8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Hepatitis C in Pregnancy
Prevalence and economic burden of extrahepatic manifestations of hepatitis Cvirus are underestimated but can be improved with therapy
Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non-medicare populations
Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis Cinfection
Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs; the case of France
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.